Phase 1 Rare Disease Trial, By Invitation NCT06368726 Sponsor: Spanish Foundation for Neurometrics Development Condition: Rare Disease
Back to Rare Disease

Phase 1 Rare Disease Trial, By Invitation

NCT06368726
By Invitation Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Children between 7 and 15 years old
  • People who have been diagnosed with Pervasive Developmental Disorder (PDD), Autism Spectrum Disorder (ASD), or PANDAS
  • People who have certain genetic changes documented in a report from a genetics specialist, such as a mutation, recombination, or other variations that occur during the formation of reproductive cells (confirm with trial site)
  • People who were born naturally, without a caesarean section or birth complications
  • People whose mother had a pregnancy without complications

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a head injury or trauma
  • People who have had a brain-affecting illness such as meningitis, encephalitis, or certain infections including SARS, Herpes, or MERS
  • People who have epilepsy
  • People who have a rare disease that also involves an autoimmune condition
  • People who have a rare disease that also involves a hormonal or endocrine condition
  • People who have a fever or unusual blood test results at their first visit to the trial
  • People who have had a reaction to a vaccine

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 1
Sponsor
Spanish Foundation for Neurometrics Development
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
12 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

FFT; Power Density Spectrum Changes or PSD; ERP MMN changes; ERP MMN Changes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov